Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group

Autor: Peyrade, Frédéric, Bologna, Serge, Delwail, Vincent, Emile, Jean François, Pascal, Laurent, Fermé, Christophe, Schiano, Jean-Marc, Coiffier, Bertrand, Corront, Bernadette, Farhat, Hassan, Fruchart, Christophe, Ghesquieres, Herve, Macro, Margaret, Tilly, Hervé, Choufi, Bachra, Delarue, Richard, Fitoussi, Olivier, Gabarre, Jean, Haioun, Corinne, Jardin, Fabrice
Zdroj: In The Lancet Haematology January 2017 4(1):e46-e55
Databáze: ScienceDirect